Vyleesi

Active Ingredient(s): Bremelanotide Acetate
FDA Approved: * June 21, 2019
Pharm Company: * AMAG PHARMS INC
Category: Women's Health / Fertility

Bremelanotide, sold under the brand name Vyleesi, is a medication used to treat low sexual desire in women.[2] Specifically it is used for low sexual desire which occurs before menopause and is not due to medical problems, psychiatric problems, or problems within the relationship.[3][4][2] It is given by an injection just under the skin of the thigh or abdomen.[2][4] Common side effects include nau... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vyleesi 1.75 mg/.3ml Subcutaneous Injection
NDC: 64011-701
Labeler:
Amag Pharmaceuticals, Inc.
Vyleesi 1.75 mg/.3ml Subcutaneous Injection
NDC: 80064-141
Labeler:
Palatin Technologies